Hain Celestial Reports Fiscal Third Quarter 2024 Financial Results
“We have taken strategic actions to simplify our portfolio and operating footprint to reduce complexity in our business and strengthen our balance sheet, which has enabled us to drive gross margin expansion, unlock operating cash flow and reduce our debt leverage,” said
FINANCIAL HIGHLIGHTS*
Summary of Fiscal Third Quarter Results Compared to the Prior Year Period
- Net sales were down 3.7% year-over year to
$438.4 million - Organic net sales, defined as net sales adjusted to exclude the impact of acquisitions, divestitures and discontinued brands, also decreased 3.7% compared to the prior year period. The decrease in organic net sales is inclusive of approximately 1.3 percentage points of benefit from foreign exchange.
- Gross profit margin was 22.1%, a 60-basis point increase from the prior year period.
- Adjusted gross profit margin was 22.3%, a 90-basis point increase from the prior year period.
- Net loss was
$48.2 million compared to net loss of$115.7 million in the prior year period.- Adjusted net income was
$11.3 million compared to adjusted net income of$7.4 million in the prior year period.
- Adjusted net income was
- Net loss margin was (11.0%), as compared to net loss margin of (25.4%) in the prior year period.
- Adjusted net income margin was 2.6%, as compared to 1.6% in the prior year period.
- Adjusted EBITDA was up 17.5% year-over-year to
$43.8 million ; Adjusted EBITDA margin was 10.0%, a 180-basis point increase compared to the prior year period. - Loss per diluted share was
$0.54 compared to loss per diluted share of$1.29 in the prior year period.- Adjusted earnings per share (“EPS”) was
$0.13 compared to adjusted EPS of$0.08 in the prior year period.
- Adjusted earnings per share (“EPS”) was
_______________
* This press release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. Reconciliations of non-GAAP financial measures to GAAP financial measures and other non-GAAP financial calculations are provided in the tables included in this press release.
Cash Flow and Balance Sheet Highlights
- Net cash provided by operating activities in the third quarter was
$42.3 million compared to$29.0 million in the prior year period. - Free cash flow in the third quarter was
$30.2 million compared to$21.6 million in the prior year period. - Total debt at the end of the fiscal third quarter was
$777.5 million down from$828.7 million at the beginning of the fiscal year. - Net debt at the end of the fiscal third quarter was
$728.0 million compared to$775.4 million at the beginning of the fiscal year. - The company ended the fiscal third quarter with a net secured leverage ratio of 3.9x as calculated under our amended credit agreement as compared to 4.3x at the beginning of the fiscal year.
SEGMENT HIGHLIGHTS
The company operates under two reportable segments:
Segment gross profit in the fiscal third quarter was
Adjusted EBITDA in the fiscal third quarter was
International
International net sales in the fiscal third quarter grew 1.0% year-over-year to
Segment gross profit in the fiscal third quarter was
Adjusted EBITDA in the fiscal third quarter was
CATEGORY HIGHLIGHTS
Quarter ended |
||||
$ millions | y/y growth | FX impact | ||
Snacks | 111.2 | -0.4% | +0.3% | |
Baby & Kids | 64.3 | -4.0% | +1.7% | |
Beverages | 68.4 | 6.7% | +0.7% | |
165.7 | -2.1% | +2.2% | ||
Personal Care | 28.8 | -33.5% | +0.1% |
Snacks
Snacks category net sales in the third quarter were
Baby & Kids
Baby & Kids category net sales in the third quarter were
Beverages
Beverages category net sales in the third quarter were
Personal Care
Personal care net sales in the third quarter were
FISCAL 2024 GUIDANCE**
The company is revising guidance for fiscal 2024 as follows:
- Organic net sales are expected to decline 3 to 4% year-over.
- Adjusted EBITDA is expected to be between
$150 million and$155 million . - Free cash flow guidance is reaffirmed and expected to be
$40 million to$45 million .
** The forward-looking non-GAAP financial measures included in this section are not reconciled to the comparable forward-looking GAAP financial measures. The company is not able to reconcile these forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures without unreasonable efforts because the company is unable to predict with a reasonable degree of certainty the type and extent of certain items that would be expected to impact GAAP measures but would not impact the non-GAAP measures. Such items may include certain litigation and related expenses, transaction costs associated with acquisitions and divestitures, productivity and transformation costs, impairments, gains or losses on sales of assets and businesses, foreign exchange movements and other items. The unavailable information could have a significant impact on the company’s GAAP financial results.
Conference Call and Webcast Information
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. The words “believe,” “expect,” “anticipate,” “may,” “should,” “plan,” “intend,” “potential,” “will” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements include, among other things: our beliefs or expectations relating to our future performance, results of operations and financial condition; our strategic initiatives (including statements related to Hain Reimagined, the consolidation of our Personal Care manufacturing, SKU rationalization and our related investments in our business); our business strategy; our brand portfolio; product performance; distribution of our products; and current or future macroeconomic trends.
Risks and uncertainties that may cause actual results to differ materially from forward-looking statements include: challenges and uncertainty resulting from the impact of competition; our ability to manage our supply chain effectively; input cost inflation, including with respect to freight and other distribution costs; disruption of operations at our manufacturing facilities; reliance on independent contract manufacturers; impairments in the carrying value of goodwill or other intangible assets; changes to consumer preferences; customer concentration; reliance on independent distributors; risks associated with operating internationally; pending and future litigation, including litigation relating to Earth’s Best® baby food products; the reputation of our company and our brands; compliance with our credit agreement; foreign currency exchange risk; the availability of organic ingredients; risks associated with outsourcing arrangements; our ability to execute our cost reduction initiatives and related strategic initiatives; risks associated with conflicts in
We undertake no obligation to update forward-looking statements to reflect actual results or changes in assumptions or circumstances, except as required by applicable law.
Non-GAAP Financial Measures
This press release and the accompanying tables include non-GAAP financial measures, including, among others, organic net sales, adjusted operating income and its related margin, adjusted gross profit and its related margin, adjusted net income and its related margin, adjusted earnings per diluted share, adjusted EBITDA and its related margin, free cash flow and net debt. The reconciliations of historic non-GAAP financial measures to the comparable GAAP financial measures are provided in the tables below. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read only in connection with the company’s consolidated financial statements presented in accordance with GAAP.
We define our non-GAAP financial measures as follows:
- Organic net sales: net sales excluding the impact of acquisitions, divestitures and discontinued brands. To adjust organic net sales for the impact of acquisitions, the net sales of an acquired business are excluded from fiscal quarters constituting or falling within the current period and prior period where the applicable fiscal quarter in the prior period did not include the acquired business for the entire quarter. To adjust organic net sales for the impact of divestitures and discontinued brands, the net sales of a divested business or discontinued brand are excluded from all periods.
- Adjusted gross profit and its related margin: gross profit, before inventory write-downs related to exited categories, plant closure related costs, net and warehouse and manufacturing consolidation and other costs, net.
- Adjusted operating income and its related margin: operating loss before certain litigation expenses, net, inventory write-downs related to exited categories, plant closure related costs, net, productivity and transformation costs, CEO succession costs, warehouse and manufacturing consolidation and other costs, net, costs associated with acquisitions, divestitures and other transactions, and intangibles and long-lived asset impairments.
- Adjusted net income and its related margin and diluted net income per common share, as adjusted: net loss, adjusted to exclude the impact of certain litigation expenses, net, inventory write-downs related to exited categories, plant closure related costs, net, productivity and transformation costs, CEO succession costs, warehouse and manufacturing consolidation and other costs, net, costs associated with acquisitions, divestitures and other transactions, (gains) losses on sales of assets, intangibles and long-lived asset impairments, unrealized currency (gains) losses and the related tax effects of such adjustments.
- Adjusted EBITDA: net loss before net interest expense, income taxes, depreciation and amortization, equity in net loss of equity-method investees, stock-based compensation, net, unrealized currency losses, certain litigation and related costs, inventory write-downs related to exited categories, plant closure related costs, net, productivity and transformation costs, CEO succession costs, warehouse and manufacturing consolidation and other costs, costs associated with acquisitions, divestitures and other transactions, (gains) losses on sales of assets, intangibles and long-lived asset impairments and other adjustments.
- Free cash flow: net cash provided by operating activities less purchases of property, plant and equipment.
- Net debt: total debt less cash and cash equivalents.
We believe that the non-GAAP financial measures presented provide useful additional information to investors about current trends in the company’s operations and are useful for period-over-period comparisons of operations. We provide:
- Organic net sales to demonstrate the growth rate of net sales excluding the impact of acquisitions, divestitures and discontinued brands, and believe organic net sales is useful to investors because it enables them to better understand the growth of our business from period to period.
- Adjusted results as important supplemental measures of our performance and believe they are frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.
- Free cash flow as one factor in evaluating the amount of cash available for discretionary investments.
- Net debt as a useful measure to monitor leverage and evaluate the balance sheet.
Investor Relations Contact:
Investor.Relations@hain.com
Media Contact:
Jen.Davis@hain.com
Consolidated Statements of Operations | ||||||||||||||||
(unaudited and in thousands, except per share amounts) | ||||||||||||||||
Third Quarter | Third Quarter Year to Date | |||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
Net sales | $ | 438,358 | $ | 455,243 | $ | 1,317,487 | $ | 1,348,802 | ||||||||
Cost of sales | 341,687 | 357,764 | 1,034,658 | 1,053,131 | ||||||||||||
Gross profit | 96,671 | 97,479 | 282,829 | 295,671 | ||||||||||||
Selling, general and administrative expenses | 66,716 | 75,047 | 217,837 | 222,355 | ||||||||||||
Intangibles and long-lived asset impairment | 49,426 | 156,583 | 70,786 | 156,923 | ||||||||||||
Productivity and transformation costs | 7,175 | 3,933 | 20,447 | 5,692 | ||||||||||||
Amortization of acquired intangible assets | 1,255 | 2,842 | 4,719 | 8,415 | ||||||||||||
Operating loss | (27,901 | ) | (140,926 | ) | (30,960 | ) | (97,714 | ) | ||||||||
Interest and other financing expense, net | 14,127 | 13,421 | 43,509 | 31,910 | ||||||||||||
Other expense (income), net | 100 | 439 | (207 | ) | (2,413 | ) | ||||||||||
Loss before income taxes and equity in net loss of equity-method investees | (42,128 | ) | (154,786 | ) | (74,262 | ) | (127,211 | ) | ||||||||
Provision (benefit) for income taxes | 5,100 | (39,587 | ) | (4,528 | ) | (30,599 | ) | |||||||||
Equity in net loss of equity-method investees | 966 | 528 | 2,371 | 1,226 | ||||||||||||
Net loss | $ | (48,194 | ) | $ | (115,727 | ) | $ | (72,105 | ) | $ | (97,838 | ) | ||||
Net loss per common share: | ||||||||||||||||
Basic | $ | (0.54 | ) | $ | (1.29 | ) | $ | (0.80 | ) | $ | (1.09 | ) | ||||
Diluted | $ | (0.54 | ) | $ | (1.29 | ) | $ | (0.80 | ) | $ | (1.09 | ) | ||||
Shares used in the calculation of net loss per common share: | ||||||||||||||||
Basic | 89,832 | 89,421 | 89,718 | 89,369 | ||||||||||||
Diluted | 89,832 | 89,421 | 89,718 | 89,369 | ||||||||||||
Consolidated Balance Sheets | ||||||||
(unaudited and in thousands) | ||||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 49,549 | $ | 53,364 | ||||
Accounts receivable, net | 191,192 | 160,948 | ||||||
Inventories | 281,399 | 310,341 | ||||||
Prepaid expenses and other current assets | 49,813 | 66,378 | ||||||
Total current assets | 571,953 | 591,031 | ||||||
Property, plant and equipment, net | 264,470 | 296,325 | ||||||
936,135 | 938,640 | |||||||
Trademarks and other intangible assets, net | 250,265 | 298,105 | ||||||
Investments and joint ventures | 10,456 | 12,798 | ||||||
Operating lease right-of-use assets, net | 87,599 | 95,894 | ||||||
Other assets | 28,356 | 25,846 | ||||||
Total assets | $ | 2,149,234 | $ | 2,258,639 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current liabilities: | ||||||||
Accounts payable | $ | 179,068 | $ | 134,780 | ||||
Accrued expenses and other current liabilities | 85,736 | 88,520 | ||||||
Current portion of long-term debt | 7,569 | 7,567 | ||||||
Total current liabilities | 272,373 | 230,867 | ||||||
Long-term debt, less current portion | 769,948 | 821,181 | ||||||
Deferred income taxes | 52,310 | 72,086 | ||||||
Operating lease liabilities, noncurrent portion | 82,435 | 90,014 | ||||||
Other noncurrent liabilities | 27,681 | 26,584 | ||||||
Total liabilities | 1,204,747 | 1,240,732 | ||||||
Stockholders' equity: | ||||||||
Common stock | 1,119 | 1,113 | ||||||
Additional paid-in capital | 1,227,684 | 1,217,549 | ||||||
Retained earnings | 580,456 | 652,561 | ||||||
Accumulated other comprehensive loss | (136,072 | ) | (126,216 | ) | ||||
1,673,187 | 1,745,007 | |||||||
Less: |
(728,700 | ) | (727,100 | ) | ||||
Total stockholders' equity | 944,487 | 1,017,907 | ||||||
Total liabilities and stockholders' equity | $ | 2,149,234 | $ | 2,258,639 | ||||
Consolidated Statements of Cash Flows | ||||||||||||||||
(unaudited and in thousands) | ||||||||||||||||
Third Quarter | Third Quarter Year to Date | |||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||||||||||
Net loss | $ | (48,194 | ) | $ | (115,727 | ) | $ | (72,105 | ) | $ | (97,838 | ) | ||||
Adjustments to reconcile net loss to net cash provided by operating activities | ||||||||||||||||
Depreciation and amortization | 10,858 | 13,784 | 34,360 | 37,909 | ||||||||||||
Deferred income taxes | (1,973 | ) | (42,826 | ) | (18,764 | ) | (44,809 | ) | ||||||||
Equity in net loss of equity-method investees | 966 | 528 | 2,371 | 1,226 | ||||||||||||
Stock-based compensation, net | 3,017 | 3,228 | 10,135 | 10,657 | ||||||||||||
Intangibles and long-lived asset impairment | 49,426 | 156,583 | 70,786 | 156,923 | ||||||||||||
(Gain) loss on sale of assets | - | (134 | ) | 62 | (3,529 | ) | ||||||||||
Other non-cash items, net | (21 | ) | 979 | 944 | (1,526 | ) | ||||||||||
(Decrease) increase in cash attributable to changes in operating assets and liabilities: | ||||||||||||||||
Accounts receivable | (25 | ) | (1,390 | ) | (30,672 | ) | (7,926 | ) | ||||||||
Inventories | 12,266 | 10,095 | 27,432 | (8,534 | ) | |||||||||||
Other current assets | 8,948 | 786 | 13,830 | 455 | ||||||||||||
Other assets and liabilities | (1,890 | ) | (682 | ) | (4,466 | ) | 3,496 | |||||||||
Accounts payable and accrued expenses | 8,896 | 3,737 | 43,046 | (20,195 | ) | |||||||||||
Net cash provided by operating activities | 42,274 | 28,961 | 76,959 | 26,309 | ||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||||||||||
Purchases of property, plant and equipment | (12,034 | ) | (7,379 | ) | (24,769 | ) | (21,434 | ) | ||||||||
Investments and joint ventures, net | - | - | - | 433 | ||||||||||||
Proceeds from sale of assets | 188 | 150 | 1,520 | 7,758 | ||||||||||||
Net cash used in investing activities | (11,846 | ) | (7,229 | ) | (23,249 | ) | (13,243 | ) | ||||||||
CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||||||||||
Borrowings under bank revolving credit facility | 30,000 | 90,000 | 152,000 | 275,000 | ||||||||||||
Repayments under bank revolving credit facility | (60,000 | ) | (110,000 | ) | (197,000 | ) | (301,000 | ) | ||||||||
Repayments under term loan | (1,875 | ) | (1,875 | ) | (5,625 | ) | (5,625 | ) | ||||||||
Payments of other debt, net | (21 | ) | (1,957 | ) | (3,875 | ) | (2,116 | ) | ||||||||
Employee shares withheld for taxes | (111 | ) | (68 | ) | (1,600 | ) | (1,051 | ) | ||||||||
Net cash used in financing activities | (32,007 | ) | (23,900 | ) | (56,100 | ) | (34,792 | ) | ||||||||
Effect of exchange rate changes on cash | (2,544 | ) | 2,413 | (1,425 | ) | (104 | ) | |||||||||
Net (decrease) increase in cash and cash equivalents | (4,123 | ) | 245 | (3,815 | ) | (21,830 | ) | |||||||||
Cash and cash equivalents at beginning of period | 53,672 | 43,437 | 53,364 | 65,512 | ||||||||||||
Cash and cash equivalents at end of period | $ | 49,549 | $ | 43,682 | $ | 49,549 | $ | 43,682 | ||||||||
(unaudited and in thousands) | ||||||||||||||||
International | Corporate/Other | Hain Consolidated | ||||||||||||||
Net sales - Q3 FY24 | $ | 268,107 | $ | 170,251 | $ | - | $ | 438,358 | ||||||||
Net sales - Q3 FY23 | $ | 286,649 | $ | 168,594 | $ | - | $ | 455,243 | ||||||||
% change - FY24 net sales vs. FY23 net sales | (6.5 | )% | 1.0 | % | (3.7 | )% | ||||||||||
Gross Profit | ||||||||||||||||
Q3 FY24 | ||||||||||||||||
Gross profit | $ | 59,237 | $ | 37,434 | $ | - | $ | 96,671 | ||||||||
Non-GAAP adjustments(1) | 406 | 691 | - | 1,097 | ||||||||||||
Adjusted gross profit | $ | 59,643 | $ | 38,125 | $ | - | $ | 97,768 | ||||||||
% change - FY24 gross profit vs. FY23 gross profit | (5.6 | )% | 7.8 | % | (0.8 | )% | ||||||||||
% change - FY24 adjusted gross profit vs. FY23 adjusted gross profit | (5.0 | )% | 9.7 | % | 0.3 | % | ||||||||||
Gross margin | 22.1 | % | 22.0 | % | 22.1 | % | ||||||||||
Adjusted gross margin | 22.2 | % | 22.4 | % | 22.3 | % | ||||||||||
Q3 FY23 | ||||||||||||||||
Gross profit | $ | 62,742 | $ | 34,737 | $ | - | $ | 97,479 | ||||||||
Non-GAAP adjustments(1) | 22 | 10 | - | 32 | ||||||||||||
Adjusted gross profit | $ | 62,764 | $ | 34,747 | $ | - | $ | 97,511 | ||||||||
Gross margin | 21.9 | % | 20.6 | % | 21.4 | % | ||||||||||
Adjusted gross margin | 21.9 | % | 20.6 | % | 21.4 | % | ||||||||||
Adjusted EBITDA | ||||||||||||||||
Q3 FY24 | ||||||||||||||||
Adjusted EBITDA | $ | 27,883 | $ | 24,547 | $ | (8,668 | ) | $ | 43,762 | |||||||
% change - FY24 adjusted EBITDA vs. FY23 adjusted EBITDA | 2.5 | % | 15.4 | % | 22.6 | % | 17.5 | % | ||||||||
Adjusted EBITDA margin | 10.4 | % | 14.4 | % | 10.0 | % | ||||||||||
Q3 FY23 | ||||||||||||||||
Adjusted EBITDA | $ | 27,193 | $ | 21,269 | $ | (11,202 | ) | $ | 37,260 | |||||||
Adjusted EBITDA margin | 9.5 | % | 12.6 | % | 8.2 | % | ||||||||||
(1) See accompanying table "Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Adjusted EPS" | ||||||||||||||||
(unaudited and in thousands) | |||||||||||||||
International | Corporate/Other | Hain Consolidated | |||||||||||||
Net sales - Q3 FY24 YTD | $ | 795,832 | $ | 521,655 | $ | - | $ | 1,317,487 | |||||||
Net sales - Q3 FY23 YTD | $ | 857,406 | $ | 491,396 | $ | - | $ | 1,348,802 | |||||||
% change - FY24 net sales vs. FY23 net sales | (7.2 | )% | 6.2 | % | (2.3 | )% | |||||||||
Gross Profit | |||||||||||||||
Q3 FY24 YTD | |||||||||||||||
Gross profit | $ | 172,115 | $ | 110,714 | $ | - | $ | 282,829 | |||||||
Non-GAAP adjustments(1) | 8,157 | 816 | - | 8,973 | |||||||||||
Adjusted gross profit | $ | 180,272 | $ | 111,530 | $ | - | $ | 291,802 | |||||||
% change - FY24 gross profit vs. FY23 gross profit | (13.7 | )% | 15.0 | % | (4.3 | )% | |||||||||
% change - FY24 adjusted gross profit vs. FY23 adjusted gross profit | (9.6 | )% | 15.8 | % | (1.3 | )% | |||||||||
Gross margin | 21.6 | % | 21.2 | % | 21.5 | % | |||||||||
Adjusted gross margin | 22.7 | % | 21.4 | % | 22.1 | % | |||||||||
Q3 FY23 YTD | |||||||||||||||
Gross profit | $ | 199,404 | $ | 96,267 | $ | - | $ | 295,671 | |||||||
Non-GAAP adjustments(1) | 74 | 10 | - | 84 | |||||||||||
Adjusted gross profit | $ | 199,478 | $ | 96,277 | $ | - | $ | 295,755 | |||||||
Gross margin | 23.3 | % | 19.6 | % | 21.9 | % | |||||||||
Adjusted gross margin | 23.3 | % | 19.6 | % | 21.9 | % | |||||||||
Adjusted EBITDA | |||||||||||||||
Q3 FY24 YTD | |||||||||||||||
Adjusted EBITDA | $ | 77,828 | $ | 67,953 | $ | (30,803 | ) | 114,978 | |||||||
% change - FY24 adjusted EBITDA vs. FY23 adjusted EBITDA | (19.3 | )% | 22.5 | % | (6.8 | )% | (6.6 | )% | |||||||
Adjusted EBITDA margin | 9.8 | % | 13.0 | % | 8.7 | % | |||||||||
Q3 FY23 YTD | |||||||||||||||
Adjusted EBITDA | $ | 96,484 | $ | 55,458 | $ | (28,836 | ) | $ | 123,106 | ||||||
Adjusted EBITDA margin | 11.3 | % | 11.3 | % | 9.1 | % | |||||||||
(1) See accompanying table "Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Adjusted EPS" |
Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Income and Adjusted EPS | |||||||||||||||
(unaudited and in thousands, except per share amounts) | |||||||||||||||
Reconciliation of Gross Profit, GAAP to Gross Profit, as Adjusted: | |||||||||||||||
Third Quarter | Third Quarter Year to Date | ||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||
Gross profit, GAAP | $ | 96,671 | $ | 97,479 | $ | 282,829 | $ | 295,671 | |||||||
Adjustments to Cost of sales: | |||||||||||||||
Plant closure related costs, net | 913 | 22 | 6,535 | 74 | |||||||||||
Warehouse/manufacturing consolidation and other costs, net | 184 | 10 | 995 | 10 | |||||||||||
Inventory write-downs related to exited categories | - | - | 1,443 | - | |||||||||||
Gross profit, as adjusted | $ | 97,768 | $ | 97,511 | $ | 291,802 | $ | 295,755 | |||||||
Reconciliation of Operating Loss, GAAP to Operating Income, as Adjusted: | |||||||||||||||
Third Quarter | Third Quarter Year to Date | ||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||
Operating loss, GAAP | $ | (27,901 | ) | $ | (140,926 | ) | $ | (30,960 | ) | $ | (97,714 | ) | |||
Adjustments to Cost of sales: | |||||||||||||||
Plant closure related costs, net | 913 | 22 | 6,535 | 74 | |||||||||||
Warehouse/manufacturing consolidation and other costs, net | 184 | 10 | 995 | 10 | |||||||||||
Inventory write-downs related to exited categories | - | - | 1,443 | - | |||||||||||
Adjustments to Operating expenses(a): | |||||||||||||||
Intangibles and long-lived asset impairment | 49,426 | 156,583 | 70,786 | 156,923 | |||||||||||
Productivity and transformation costs | 7,175 | 3,933 | 20,447 | 5,692 | |||||||||||
Certain litigation expenses, net(b) | 458 | (1,582 | ) | 4,073 | 3,363 | ||||||||||
Plant closure related costs, net | 232 | - | 179 | (1 | ) | ||||||||||
Transaction and integration costs, net | 55 | 215 | 282 | 1,984 | |||||||||||
CEO succession | - | - | - | 5,113 | |||||||||||
Warehouse/manufacturing consolidation and other costs, net | - | 3,982 | - | 2,569 | |||||||||||
Operating income, as adjusted | $ | 30,542 | $ | 22,237 | $ | 73,780 | $ | 78,013 | |||||||
Reconciliation of Net Loss, GAAP to Net Income, as Adjusted: | |||||||||||||||
Third Quarter | Third Quarter Year to Date | ||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||
Net loss, GAAP | $ | (48,194 | ) | $ | (115,727 | ) | $ | (72,105 | ) | $ | (97,838 | ) | |||
Adjustments to Cost of sales: | |||||||||||||||
Plant closure related costs, net | 913 | 22 | 6,535 | 74 | |||||||||||
Warehouse/manufacturing consolidation and other costs, net | 184 | 10 | 995 | 10 | |||||||||||
Inventory write-downs related to exited categories | - | - | 1,443 | - | |||||||||||
Adjustments to Operating expenses(a): | |||||||||||||||
Intangibles and long-lived asset impairment | 49,426 | 156,583 | 70,786 | 156,923 | |||||||||||
Productivity and transformation costs | 7,175 | 3,933 | 20,447 | 5,692 | |||||||||||
Certain litigation expenses, net(b) | 458 | (1,582 | ) | 4,073 | 3,363 | ||||||||||
Plant closure related costs, net | 232 | - | 179 | (1 | ) | ||||||||||
Transaction and integration costs, net | 55 | 215 | 282 | 1,984 | |||||||||||
CEO succession | - | - | - | 5,113 | |||||||||||
Warehouse/manufacturing consolidation and other costs, net | - | 3,982 | - | 2,569 | |||||||||||
Adjustments to Interest and other expense, net(c): | |||||||||||||||
Unrealized currency (gains) losses | (71 | ) | 202 | 83 | 651 | ||||||||||
(Gain) loss on sale of assets | - | (134 | ) | 62 | (3,529 | ) | |||||||||
Adjustments to Provision (benefit) for income taxes: | |||||||||||||||
Net tax impact of non-GAAP adjustments | 1,094 | (40,131 | ) | (14,139 | ) | (40,151 | ) | ||||||||
Net income, as adjusted | $ | 11,272 | $ | 7,373 | $ | 18,641 | $ | 34,860 | |||||||
Net loss margin | (11.0 | )% | (25.4 | )% | (5.5 | )% | (7.3 | )% | |||||||
Adjusted net income margin | 2.6 | % | 1.6 | % | 1.4 | % | 2.6 | % | |||||||
Diluted shares used in the calculation of net (loss) income per common share: | 89,832 | 89,421 | 89,718 | 89,369 | |||||||||||
Diluted net loss per common share, GAAP | $ | (0.54 | ) | $ | (1.29 | ) | $ | (0.80 | ) | $ | (1.09 | ) | |||
Diluted net income per common share, as adjusted | $ | 0.13 | $ | 0.08 | $ | 0.21 | $ | 0.39 | |||||||
(a) Operating expenses include amortization of acquired intangibles, selling, general and administrative expenses, intangibles and long-lived asset impairment and productivity and transformation costs. | |||||||||||||||
(b) Expenses and items relating to securities class action, baby food litigation and |
|||||||||||||||
(c) Interest and other expense, net includes interest and other financing expenses, net, unrealized currency (gains) losses, (gain) loss on sale of assets and other expense, net. | |||||||||||||||
Organic Net Sales Growth | |||||||||||
(unaudited and in thousands) | |||||||||||
Q3 FY24 | International | Hain Consolidated | |||||||||
Net sales | $ | 268,107 | $ | 170,251 | $ | 438,358 | |||||
Divestitures and discontinued brands | (307 | ) | - | (307 | ) | ||||||
Organic net sales | $ | 267,800 | $ | 170,251 | $ | 438,051 | |||||
Q3 FY23 | |||||||||||
Net sales | $ | 286,649 | $ | 168,594 | $ | 455,243 | |||||
Divestitures and discontinued brands | (163 | ) | - | (163 | ) | ||||||
Organic net sales | $ | 286,486 | $ | 168,594 | $ | 455,080 | |||||
Net sales (decline) growth | (6.5 | )% | 1.0 | % | (3.7 | )% | |||||
Impact of divestitures and discontinued brands | 0.0 | % | 0.0 | % | 0.0 | % | |||||
Organic net sales (decline) growth | (6.5 | )% | 1.0 | % | (3.7 | )% | |||||
Q3 FY24 YTD | International | Hain Consolidated | |||||||||
Net sales | $ | 795,832 | $ | 521,655 | $ | 1,317,487 | |||||
Divestitures and discontinued brands | (299 | ) | - | (299 | ) | ||||||
Organic net sales | $ | 795,533 | $ | 521,655 | $ | 1,317,188 | |||||
Q3 FY23 YTD | |||||||||||
Net sales | $ | 857,406 | $ | 491,396 | $ | 1,348,802 | |||||
Divestitures and discontinued brands | (3,073 | ) | - | (3,073 | ) | ||||||
Organic net sales | $ | 854,333 | $ | 491,396 | $ | 1,345,729 | |||||
Net sales (decline) growth | (7.2 | )% | 6.2 | % | (2.3 | )% | |||||
Impact of divestitures and discontinued brands | 0.3 | % | 0.0 | % | 0.2 | % | |||||
Organic net sales (decline) growth | (6.9 | )% | 6.2 | % | (2.1 | )% | |||||
Adjusted EBITDA | |||||||||||||||
(unaudited and in thousands) | |||||||||||||||
Third Quarter | Third Quarter Year to Date | ||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||
Net loss | $ | (48,194 | ) | $ | (115,727 | ) | $ | (72,105 | ) | $ | (97,838 | ) | |||
Depreciation and amortization | 10,858 | 13,784 | 34,360 | 37,909 | |||||||||||
Equity in net loss of equity-method investees | 966 | 528 | 2,371 | 1,226 | |||||||||||
Interest expense, net | 13,322 | 12,924 | 41,278 | 30,582 | |||||||||||
Provision (benefit) for income taxes | 5,100 | (39,587 | ) | (4,528 | ) | (30,599 | ) | ||||||||
Stock-based compensation, net | 3,017 | 3,228 | 10,135 | 10,657 | |||||||||||
Unrealized currency losses | 250 | 202 | 91 | 651 | |||||||||||
Certain litigation expenses, net(a) | 458 | (1,582 | ) | 4,073 | 3,363 | ||||||||||
Restructuring activities | |||||||||||||||
Productivity and transformation costs | 7,175 | 3,933 | 20,447 | 5,692 | |||||||||||
Plant closure related costs, net | 1,145 | 22 | 5,288 | 73 | |||||||||||
Warehouse/manufacturing consolidation and other costs, net | 184 | 2,871 | 995 | 899 | |||||||||||
CEO succession | - | - | - | 5,113 | |||||||||||
Acquisitions, divestitures and other | |||||||||||||||
Transaction and integration costs, net | 55 | 215 | 282 | 1,984 | |||||||||||
(Gain) loss on sale of assets | - | (134 | ) | 62 | (3,529 | ) | |||||||||
Impairment charges | |||||||||||||||
Intangibles and long-lived asset impairment | 49,426 | 156,583 | 70,786 | 156,923 | |||||||||||
Inventory write-downs related to exited categories | - | - | 1,443 | - | |||||||||||
Adjusted EBITDA | $ | 43,762 | $ | 37,260 | $ | 114,978 | $ | 123,106 | |||||||
(a) Expenses and items relating to securities class action, baby food litigation and |
|||||||||||||||
Free Cash Flow | |||||||||||||||
(unaudited and in thousands) | |||||||||||||||
Third Quarter | Third Quarter Year to Date | ||||||||||||||
2024 | 2023 | 2024 | 2023 | ||||||||||||
Net cash provided by operating activities | $ | 42,274 | $ | 28,961 | $ | 76,959 | $ | 26,309 | |||||||
Purchases of property, plant and equipment | (12,034 | ) | (7,379 | ) | (24,769 | ) | (21,434 | ) | |||||||
Free cash flow | $ | 30,240 | $ | 21,582 | $ | 52,190 | $ | 4,875 | |||||||
Net Debt | |||||
(unaudited and in thousands) | |||||
Debt | |||||
Long-term debt, less current portion | $ | 769,948 | $ | 821,181 | |
Current portion of long-term debt | 7,569 | 7,567 | |||
Total debt | $ | 777,517 | $ | 828,748 | |
Less: Cash and cash equivalents | 49,549 | 53,364 | |||
Net debt | $ | 727,968 | $ | 775,384 | |
Source: The Hain Celestial Group, Inc.